PT - JOURNAL ARTICLE AU - Rauch, Barbara AU - Kern-Matschilles, Stefanie AU - Haschka, Stefanie J. AU - Sacco, Vanessa AU - Potzel, Anne L. AU - Banning, Friederike AU - Benz, Irina AU - Meisel, Mandy AU - Seissler, Jochen AU - Gar, Christina AU - Lechner, Andreas TI - COVID-19-related symptoms 6 months after the infection - Update on a prospective cohort study in Germany AID - 10.1101/2021.02.12.21251619 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.12.21251619 4099 - http://medrxiv.org/content/early/2021/02/13/2021.02.12.21251619.short 4100 - http://medrxiv.org/content/early/2021/02/13/2021.02.12.21251619.full AB - Objective Many anecdotal reports indicate the presence of ‘long COVID’ – COVID-19-related symptoms weeks to months after the acute illness. However, frequency and symptom-pattern of ‘long COVID’ in relation to acute disease severity are uncertain. As part of an ongoing, prospective cohort study we therefore conducted an online survey among adults 6 months after acute COVID-19.Methods The prospective online study Life&Covid is ongoing in Germany since May 2020. Participants were recruited 0 to 4 months after their SARS-CoV-2 infection und followed up by subsequent surveys. The survey 6 months after the infection was completed by 127 out of 148 individuals invited by email (86%). All grades of acute disease severity were included and 91% of the participants had been treated as outpatients during their acute illness.Results Six months after the infection, 67% of the study participants reported at least one symptom as a consequence of COVID-19. Exertional dyspnea (30% of participants), fatigue (25%) and diminished sense of taste/smell (19%) were the most common individual symptoms. At least one symptom, exertional dyspnea, and fatigue were reported more often after a severe acute illness, but diminished sense of taste/smell was unrelated to acute severity. Age group and sex did not associate with the frequency of symptoms at 6 months.Conclusions Based on this study, the prevalence of COVID-19-related symptoms 6 months after the infection is high. Some bias for overestimation may have affected this result. Nevertheless, ‘long COVID’ requires attention in medical care and a better scientific understanding.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by LMU Klinikum Muenchen, Helmholtz Zentrum Muenchen, and the German Center for Diabetes Research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the ethics committee of the medical faculty of the Ludwig-Maximilians-Universitaet in Munich, Germany.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnonymized study data is available from the corresponding author upon reasonable request.